Post-Conference Perspectives: Breast Cancer Recurrence Monitoring by ctDNA

Aditya Bardia, MD, MPH discusses the present and prospective clinical applications of ctDNA monitoring informed by promising data presented at the ASCO 2022 Annual Meeting.

EP. 1: Best Practices for Assessing Risk of Recurrence in Patients with Breast Cancer

August 31st 2022

Aditya Bardia, MD, MPH shares his approach to assessing breast cancer recurrence risk and monitoring patients during and after treatment.

EP. 2: Clinical Evidence Supporting the use of ctDNA to Detect Recurrence

August 31st 2022

A breast cancer expert provides a brief overview of clinical evidence supporting the use of ctDNA to detect recurrence.

EP. 3: Data Review: ctDNA Monitoring in Patients with Breast Cancer

August 31st 2022

Dr. Bardia reviews data from the ASCO 2022 Annual Meeting, focusing on serial postoperative ctDNA monitoring for breast cancer recurrence.

EP. 4: Practical Clinical Applications for ctDNA Assessment

August 31st 2022

Clinical pearls addressing the current and potential future applications of ctDNA in breast cancer monitoring strategies.

EP. 5: Technical and Logistical Challenges Concerning the use of ctDNA Monitoring

August 31st 2022

Experienced clinician shares insight on potential challenges in the use of ctDNA monitoring.

EP. 6: Promising Strategies for Assessing Risk and Detecting Recurrence Earlier

August 31st 2022

Dr. Bardia discusses promising biomarkers and strategies for helping assess risk and detect recurrence in breast cancer.